- Trials with a EudraCT protocol (43)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
43 result(s) found for: Flu-like symptoms.
Displaying page 1 of 3.
EudraCT Number: 2013-001869-16 | Sponsor Protocol Number: BRN-C-2013-02 | Start Date*: 2013-09-24 | |||||||||||
Sponsor Name:Boiron Laboratoires | |||||||||||||
Full Title: A randomised, multi-centre, parallel group, double-blind, placebo-controlled study to assess the efficacy and safety of Oscillococcinum® in the treatment of symptoms of Influenza-like illness (ILI) | |||||||||||||
Medical condition: Systemic and respiratory symptoms of Influenza-like-illness (ILI) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016267-11 | Sponsor Protocol Number: C09-30 | Start Date*: 2009-10-23 | |||||||||||
Sponsor Name:Inserm | |||||||||||||
Full Title: Etude des réponses immunitaires après vaccination anit-influenza saisonnier et anti-H1N1 variant pandémique dans une population de personnel soignant. | |||||||||||||
Medical condition: symptome de la grippe | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016659-23 | Sponsor Protocol Number: C09-32 | Start Date*: 2009-10-26 | |||||||||||
Sponsor Name:Inserm | |||||||||||||
Full Title: Etude de phase II évaluant l'immunogénicité et la tolérance d'un vaccin inactivé non adjuvanté contre la grippe A (H1N1) après transplantation rénale | |||||||||||||
Medical condition: grippe A/H1N1 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016660-36 | Sponsor Protocol Number: C09-33 | Start Date*: 2009-10-26 | |||||||||||
Sponsor Name:Inserm | |||||||||||||
Full Title: Etude de phase II évaluant l'immunogénicité et la tolérance d'un vaccin inactivé non adjuvanté contre la grippe A/H1N1v chez la femme enceinte | |||||||||||||
Medical condition: Grippe A H1N1 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015160-34 | Sponsor Protocol Number: C09-24 | Start Date*: 2009-10-05 | |||||||||||
Sponsor Name:INSERM | |||||||||||||
Full Title: "COhort on FLU during PREGnancy" Etude de cohorte évaluant l'expression clinique et le retentissement materno-foetal de la grippe survenant au cours de la grossesse. | |||||||||||||
Medical condition: Femmes enceintes présentant des signes d'infection de la grippe en période de pandémie de grippe A. | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015100-25 | Sponsor Protocol Number: C09-24 | Start Date*: 2009-10-09 | |||||||||||
Sponsor Name:INSERM | |||||||||||||
Full Title: Cohorte multicentrique nationale de patients atteints de grippe pandémique (nouveau virus A/H1N1v d’origine porcine) | |||||||||||||
Medical condition: Forme grave et forme bénigne de la Grippe A | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004471-23 | Sponsor Protocol Number: CB/ALICE/0010 | Start Date*: 2015-08-12 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: Antivirals for influenza Like Illness? An rCt of Clinical and Cost effectiveness in primary CarE | |||||||||||||
Medical condition: Influenza-like illness | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BE (Completed) IE (Completed) GB (Completed) SE (Completed) CZ (Completed) LT (Completed) DK (Completed) NL (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001055-12 | Sponsor Protocol Number: BIIT0212 | Start Date*: 2015-05-28 | |||||||||||
Sponsor Name:Biogen Idec Italia S.r.l. | |||||||||||||
Full Title: Flu-like syndrome Inhibition Giving anti-histaminic Therapy. Randomized cross-over, single-center, randomized, placebo-controlled, double-blind study to evaluate the efficacy of cetirizine on Flu-l... | |||||||||||||
Medical condition: Patients with relapsing remitting multiple sclerosis (RRMS) treated with interferoneβ, suffering from flu-like syndrome (FLS). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002972-11 | Sponsor Protocol Number: BRN-C-2019-02 | Start Date*: 2020-09-21 |
Sponsor Name:BOIRON | ||
Full Title: Efficacy of Oscillococcinum® in the treatment of Influenza-like-illness symptoms: a national, multicentre, randomized, controlled trial | ||
Medical condition: Influenza-like illness (ILI) symptoms | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-003559-32 | Sponsor Protocol Number: CPO19001 | Start Date*: 2023-03-16 | ||||||||||||||||
Sponsor Name:PharOS Pharmaceutical Oriented Services Single Member Ltd. | ||||||||||||||||||
Full Title: A Phase III Prospective, Randomized, Multicenter, Double-Blind, Placebo-controlled clinical study to evaluate the efficacy and safety of fixed dose combination (FDC) product Ibuprofen/Paracetamol/P... | ||||||||||||||||||
Medical condition: Temporary relief of cold and flu symptoms, i.e. mild to moderate pain, sore throat, fever and nasal congestion | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: BG (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004885-14 | Sponsor Protocol Number: AI452-017 | Start Date*: 2012-11-20 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a, with and without Daclatasvir, Compared to Peginterferon Alfa-2a, Each in Combina... | |||||||||||||
Medical condition: Chronic Hepatitis C | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) FI (Completed) NL (Completed) IT (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004450-21 | Sponsor Protocol Number: EMR200136-570 | Start Date*: 2014-02-07 | |||||||||||
Sponsor Name:Merck Serono S.p.A. | |||||||||||||
Full Title: Multicenter, open-label, 12 weeks, phaseIV pRospectivE randomized study aimed at evaLuating whether sc IFN beta 1a (Rebif®) administered In the morning may affEct the severity of Flu-like syndrom... | |||||||||||||
Medical condition: relapsing multiple sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003508-11 | Sponsor Protocol Number: AI452-033 | Start Date*: 2013-08-09 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: A Double-Blinded, Randomized Control Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a Compared to Peginterferon alfa-2a, Each in Combination with Ribavirin, in the Treatment of N... | |||||||||||||
Medical condition: Chronic Hepatitis C Virus Infection (Genotype 1) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000867-24 | Sponsor Protocol Number: ALFR-HC-04 | Start Date*: 2005-05-23 |
Sponsor Name:Human Genome Sciences, Inc. | ||
Full Title: A PHASE 2b, RANDOMIZED, MULTI-CENTER, ACTIVE-CONTROLLED, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALBUFERON (RECOMBINANT HUMAN ALBUMIN-INTERFERON ALFA FUSION PROTEIN) IN COMBINATION... | ||
Medical condition: Hepatitis type C chronic | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-003463-22 | Sponsor Protocol Number: AI452-030 | Start Date*: 2013-03-13 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: MAGNITUDE - A Phase 3 Evaluation of the Safety and Efficacy of Lambda/RBV/DCV in Treatment Naïve Subjects with Chronic HCV Infection, who have Underlying Mild or Moderate Hemophilia or Patients who... | |||||||||||||
Medical condition: Chronic Hepatitis C Virus Infection (Genotype 1b, 2, 3, 4) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: ES (Temporarily Halted) IT (Prematurely Ended) NL (Completed) FR (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003280-22 | Sponsor Protocol Number: AI452-032 | Start Date*: 2013-08-13 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: Phase 3 open label study evaluating the efficacy and safety of pegylated interferon lambda-1a, in combination with ribavirin and daclatasvir, for treatment of chronic HCV infection with treatment n... | |||||||||||||
Medical condition: Chronic Hepatitis C Virus (HCV) Infection (Genotypes 1, 2, 3, 4) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) IT (Completed) DE (Completed) ES (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005409-65 | Sponsor Protocol Number: AI452-021 | Start Date*: 2013-01-18 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: A Phase 3 Evaluation of Daclatasvir in Combination with Peginterferon Lambda-1a and Ribavirin (RBV) or Telaprevir in Combination with Peginterferon Alfa-2a and RBV in Patients with Chronic Hepatiti... | |||||||||||||
Medical condition: Chronic Hepatitis C Virus Infection (Genotype 1b) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) IT (Completed) DE (Completed) PL (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017003-28 | Sponsor Protocol Number: BD0109 | Start Date*: 2010-04-12 | ||||||||||||||||||||||||||
Sponsor Name:BIOGEN-DOMPE` SRL | ||||||||||||||||||||||||||||
Full Title: Relationship between IL-6 and TNF-α polymorphism and flu-like syndrome development in multiple sclerosis patients treated with Interferon-beta 1a i.m. Open label multicentre study | ||||||||||||||||||||||||||||
Medical condition: multiple sclerosis | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-000057-31 | Sponsor Protocol Number: ESTUAR001 | Start Date*: 2012-03-19 | ||||||||||||||||||||||||||
Sponsor Name:THERANOR sprl | ||||||||||||||||||||||||||||
Full Title: Multicentre, randomised, double-blind, parallel, placebo-controlled study evaluating the efficacy and safety of Early Self-Treatment of viral Upper respiratory tract infections with homeopathic ora... | ||||||||||||||||||||||||||||
Medical condition: Viral upper respiratory tract infections | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005293-70 | Sponsor Protocol Number: MS04.03 | Start Date*: 2006-06-19 |
Sponsor Name:Emergent Product Development UK Ltd | ||
Full Title: A double blind, placebo controlled study to evaluate the safety and immunogenicity of escalating doses of 108 CFU, 109 CFU and 1010 CFU of M04NM11 in patients who have chronic Hepatitis B infection. | ||
Medical condition: Chronic hepatitis B virus infection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
